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Objective: To determine the complication rate during the catheterization in adults
with congenital heart disease (CHD) in a pediatric catheterization laboratory
(PCL). Background: An increasing number of patients with CHD are surviving into
adulthood, with diagnostic and interventional cardiac catheterization being
essential for the management of their disease. The complication rate during the
catheterization of adults with CHD has not been reported. Methods: A retrospec-
tive chart review was performed on all adult patients (>18 years) with CHD who
underwent diagnostic or interventional catheterization in our PCL within the past
8.5 years. Results: A total of 576 procedures were performed on 436 adult
patients (median age 26 years). Complex heart disease was present in 387/576
(67%) procedures. An isolated atrial septal defect or patent foramen ovale was
present in 115/576 (20%) procedures, and 51/576 (9%) procedures were per-
formed on patients with structurally normal hearts with arrhythmias. Interven-
tional catheterization was performed in 378/576 (66%) procedures. There were
complications during 61/576 (10.6%) procedures; 19 were considered major and
42 minor. Major complications were death (1), ventricular fibrillation (1), hypoten-
sion requiring inotropes (7), atrial flutter (3), retroperitoneal hematoma, pneumo-
thorax, hemothorax, aortic dissection, renal failure, myocardial ischemia and
stent malposition (1 each). The most common minor complications were vascular
entry site hematomas and hypotension not requiring inotropes. Procedures per-
formed on patients ≥ 45 years of age had a 19% occurrence of complications
overall compared with 9% occurrence rate in patients of age < 45 years (P <
0.01). Conclusions: The complication rate during the catheterization of adults with
CHD in a PCL is similar to the complication rate of children with CHD undergoing
cardiac catheterization. The older subset of patients are more likely to encounter
complications overall. The encountered complications could be handled effec-
tively in the PCL. With screening in place, it is safe to perform cardiac catheter-
ization on most adults with CHD in a PCL. ' 2005 Wiley-Liss, Inc.
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INTRODUCTION
During the last two decades, dramatic advances have
been made in the management of congenital heart dis-
ease (CHD). Approximately 85% of infants born today
with CHD are expected to live into adulthood [1–5].
Many of these adult patients will require diagnostic or
interventional cardiac catheterization for management
of their CHD. Furthermore, adults with atrial septal
defect (ASD) and patent foramen ovale (PFO) are
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undergoing cardiac catheterization for percutaneous clo-
sure of these defects [6]. Although the safety of per-
forming catheterization in pediatric and adult patients
has been reported, there is no data on the complication
rate in performing cardiac catheterization in adults with
CHD. The following study evaluates the overall compli-
cation rate during diagnostic and therapeutic cardiac
catheterization of adults with CHD in a pediatric cathe-
terization laboratory (PCL).
METHODS
A retrospective chart review was performed on all
patients aged 18 years who underwent cardiac cathe-
terization in our PCL situated in a free-standing child-
ren’s hospital, between January 1996 and October 2004.
Technical and nursing staffs in the PCL were ACLS cer-
tified. Informed consent was obtained prior to the cathe-
terization in all patients. Patients older than 30 years
were initially screened by either an adult or pediatric car-
diologist for evidence of ongoing ischemic heart disease
with a complete medical history, electrocardiogram,
echocardiogram, and stress testing as applicable. Patients
with poorly controlled ischemic heart disease were
referred to an adult cardiologist for management of the
ischemic heart disease; after which they could be sent
back to the PCL for the procedure. Patient age, weight,
gender, diagnosis, history of arrhythmias, hypertension,
stroke, NYHA classification, and other comorbid condi-
tions were noted. Diagnoses were classified into complex
CHD, minor CHD (ASD/PFO/patent ductus arteriosus/
aorto-pulmonary collaterals), or anatomically normal
hearts with arrhythmias. The procedures were classified
as either diagnostic or interventional. Complications as-
sociated with the catheterization were considered major
(unanticipated complications within 24 hr of the proce-
dure that required intervention, close observation, or
resulted in death) or minor (all other complications).
Arrhythmias occurring during electrophysiology study or
with catheter manipulation were not included. Other data
including use of general anesthesia and length of hospital
stay were noted. Patients were arbitrarily divided into
two groups based on age (group 1: patients < 45 years
of age, and group 2: patients  45 years of age).
Statistical Analysis
All data are presented as sample number with per-
centages in parenthesis, unless otherwise indicated.
Continuous variables are expressed as mean (6SD) or
median (range). Comparisons on categorically scaled
variables between groups were examined using a non-
parametric Fisher’s exact v2 test. Statistically significant
differences in means or proportions were considered
achieved at a P-value  0.05, two-tailed. All statistical
analyses were performed using Microsoft Excel and
SPSS Version 11.5.
RESULTS
Baseline demographic and clinical data for the pa-
tient population are given in Table I.
A total of 576 catheterizations were performed on
436 adult patients during the 8.5-year study period.
Complex CHD was present in 387/576 (67%) proce-
dures. The most common complex CHDs were: Tetral-
ogy of Fallot with complete repair, 74/387 (19%);
Fontan palliation for single ventricle, 62/387 (16%);
simple transposition of the great arteries with Mustard
palliation, 55/387 (14%); and semilunar valve stenosis,
44/387 (11%). Minor CHD was present in 134/576 (24%)
procedures, including 115/576 (20%) isolated ASD/PFO.
In addition, there were four procedures in which a trans-
esophageal echocardiogram (TEE) performed at an out-
side institution indicated a PFO, but no PFO was seen
upon repeating a TEE in our PCL prior to cardiac cath-
eterization. Arrhythmia diagnosis/treatment was per-
formed in 51/576 (9%) procedures in patients with struc-
turally normal hearts. Only 3/576 (<1%) procedures
were performed on patients with known stable coronary
artery disease. There were no patients with poorly con-
trolled ischemic heart disease that required an urgent/
semiurgent CC in the PCL. General anesthesia was used
in 310/576 (54%) procedures of which 237 (76%) were
interventional procedures.
Interventional catheterization was performed in 378/
576 (66%) procedures (Table II). Percutaneous closure
of ASD/PFO was the most common interventional pro-
cedure. General anesthesia was used during 75% of the
ASD/PFO procedures. Intracardiac echocardiography
was not available during the study period.
TABLE I. Demographics and Clinical Characteristics
N
Age (yrs) Median (range) 26 (18–78)
Males (%) 285 (49)
Weight (kg) Median (range) 67 (31–164)
Reason for cardiac catheterization
Diagnostic (%) 193 (34)
Interventional (%) 378 (66)
Missing data (%) 5 (0.7)
Disease classification
Minor CHD (%) 134 (23)
Complex CHD (%) 387 (67)
Arrhythmias only (%) 51 (9)
Assumed PFO (%) 4 (0.7)
Hypertension (%) 39 (7)
Stroke/transient ischemic attack (%) 86 (15)
NYHA Classification III and IV (%) 73 (16)
General anesthesia (%) 310 (53)
Medications (at least three medications) (%) 135 (23)
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Patients in group 1 (age < 45 years) made up 480/
576 (83%) procedures and patients in group 2 (age 
45 years) made up 96/576 (17%) procedures (Table III).
The occurrence of NYHA class 3 or 4 failure was not
statistically different between group 1 and group 2. The
presence of complex CHD was significantly greater in
group 1 than in group 2 (77% vs. 19%; P < 0.01).
Patients older than 30 years were transferred from
the PCL to the adjacent adult hospital if overnight stay
was required for recovery (hospital policy). This
occurred in 17.5% of the procedures.
Discharge from the hospital within 24 hr of the pro-
cedure was accomplished in 508/576 (89%) procedures.
Complications. A total of 61 (10.6%) complications
were encountered. There were 19 (3.2%) major and 42
(7.3%) minor complications. Hypotension was classified
under major complications if inotropic support was
required in addition to fluid resuscitation and under
minor complications if fluid resuscitation alone was suf-
ficient.
Major complications. Major complications (Table
IV) were encountered during 10/387 (2.5%) procedures
in patients with complex CHD, in comparison to 9/189
(4.8%) procedures in patients without complex CHD
(P ¼ NS). More than half of the major complications
(12/19) occurred during interventional procedures. The
only death occurred in a 26-year-old patient during
pacemaker placement because of postoperative com-
plete atrioventricular block. The patient developed ven-
tricular tachycardia that degenerated into fatal ventri-
cular fibrillation. Major complications during device
closure of ASD/PFO occurred in 7 patients of whom 3
had atrial flutter and 2 encountered hypotension. At
follow-up of patients encountering atrial flutter, all 3
patients were in sinus rhythm and off anti-arrhythmic
medication. Hypotension as a complication was seen in
7 procedures of which 6 were performed under general
anesthesia. All episodes of hypotension are resolved by
the end of the catheterization procedure with use of ino-
tropic drips. ST segment elevation in the inferior leads
was observed during closure of a PFO in one patient
with a history of coronary artery bypass surgery. The
elevation was transient and responded to administration
of nitroglycerin and oxygen. There was no correlation
between NYHA class and major complications.
Minor complications. Minor complications (Table V)
occurred in 42/576 (7.3%) catheterizations. The most fre-
quent minor complications were vascular access site hema-
toma (n ¼ 20) and isolated transient hypotension (n ¼ 5)
that was responsive to volume resuscitation. All vascular
site hematomas resolved spontaneously within 1 week of
the procedure.
Comparison between groups 1 and group 2. Com-
plications, overall, were significantly more likely to
occur in group 2 in comparison to group 1 (P < 0.01).
There were no significant differences between group 1
and group 2 with regard to number of major complica-
tions (Table V). Group 2 had a significantly higher inci-
dence of minor complications (P < 0.05). Group 2 was
also significantly more likely to have hypotension (re-
quiring fluid and/or inotropes) (7/96) compared with that
of group 1 (5/480), P ¼ 0.001. There was no significant
difference in the incidence of hematomas between the
two groups.
DISCUSSION
Cardiac catheterization of adults with CHD presents
a unique situation. Although adult cardiologists are
clearly more experienced in performing adult catheteri-
zations and in dealing with other comorbid adult issues,
pediatric cardiologists have more experience in catheter-
ization of patients with CHD. Also, a PCL has biplane
imaging with its obvious advantages for a patient with
complex CHD. With the prevalence of adults with CHD
becoming greater, the question arises as to who is better
equipped to treat this growing population. The optimal
place to perform catheterization on adults with CHD has
also not been determined. Additionally, although the com-
plication rate for cardiac catheterizations in infants and
children with CHD [7–11] and in adults with acquired
heart disease is known [12,13], there is no information on
the complication rate in performing cardiac catheteriza-
tions in adults with CHD.
In this study of adults with CHD catheterized in a
pediatric facility, the overall complication rate was
10.6% with a mortality rate of 0.17%. This is similar to
the reported complication rate of 8–12% and mortality
rate of 0.14–0.5% for pediatric patients with CHD
catheterized in a pediatric facility [7–11]. However, it
must be noted that this comparison is with studies per-
TABLE II. Distribution of Interventional Cardiac
Catheterizations
Procedures n (%)
ASD/PFO closure 115 (30.6)
Pacemaker placement 86 (23)
Radio-frequency ablation 49 (13)
Angioplasty (pulmonary artery or




Coarctation stent/angioplasty 6 (1.6)
Angioplasty þ pacemaker placement 5 (1.3)
Biopsy þ pacemaker placement 1 (0.3)
aIncludes PDA or aortopulmonary collateral coil embolization, balloon
pericardiotomy, and thrombectomy.
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formed at least 5 years ago; there are no other recent
studies available. The rate is also similar to the compli-
cation rate of 8% and a mortality rate of 0.2% in adults
catheterized at an adult facility secondary to acquired
heart disease [12,13]. In our experience, major compli-
cations were not significantly associated with the older
subset of patients, interventional procedures, or with
procedures on patients with complex CHD.
TABLE III. Comparison of Procedures Performed on Patients <45 Years or ≥45 Years
Group 1
(age <45 yrs;
n ¼ 480) (%)
Group 2
(age  45 yrs;
n ¼ 96) (%) P
Mean age 6 SD (yrs) 26 6 7 54 6 7.7 <0.01
Males 250 34 <0.01
NYHA failure class 3 or 4 58 (12) 15 (16) 0.31
Coronary artery disease 0 3 (3) <0.01
Complex CHD 369 (77) 18 (19) <0.01
Procedures on patients with TGA with
Mustard repair or Tetralogy repair or
Fontan palliation in the complex
CHD group 189 (39) 2 (2) <0.01
Number of interventional catheterizations 300 (63) 78 (80) <0.01
ASD/PFO closure (% of all procedures) 47 (9.8) 68 (70) <0.01
Pacemaker placement 83 (17) 3 (3) <0.01
Complications 43 (9) 18 (19) <0.01
Minor Complications 30 (6.3) 12 (11.5) 0.04
Major Complications 13 (2.7) 6 (6.3) 0.10
Hypotension (requiring fluids
and/or inotropes) 5 (1) 7 (7) <0.01
TABLE IV. Major Complications
Complication Age (yrs) Diagnosis Procedure Disposition
1. Sustained ventricular
tachycardia/fibrillation 26 VSD repaired, complete AV block Pacemaker placement Death
2. Ventricular fibrillation 31 Complex single ventricle
s/p Fontan Diagnostic Defibrillation
3. Atrial flutter 52 PFO PFO closure Institution of antiarrhythmic
medication
4. Atrial flutter 44 ASD ASD closure Institution of antiarrhythmic
medication
5. Atrial flutter 55 ASD ASD closure Institution of antiarrhythmic
medication
6. Hemothorax 25 Tricuspid atresia s/p Fontan Hemodynamic evaluation Placement of chest tube
7. Pneumothorax 25 Truncus arteriosus repaired, AV block Pacemaker placement Placement of chest tube
8. Retroperitoneal hematoma 37 PFO PFO closure Spontaneous resolution; no
intervention
9. Aortic dissection 40 Coarctation of aorta Stent placement Antihypertensive drips






18 L-TGA, VSD, PS s/p repair Stent placement in conduit Repositioning of stent
12. Hypotension 52 Assumed PFO TEE, right heart
catheterization Inotrope infusion
13. Hypotension 22 Tetrology of Fallot/pulmonary atresia Hemodynamic evaluation Inotrope infusion
14. Hypotension 65 Assumed PFO TEE, right heart
catheterization Inotrope infusion
15. Hypotension 18 TGA/Mustard repair Hemodynamic evaluation Inotrope infusion
16. Hypotension 40 PFO PFO closure Inotrope infusion
17. Hypotension 24 Pulmonary atresia/intact ventricular
septum Hemodynamic evaluation Inotrope infusion
18. Hypotension 52 ASD ASD closure Inotrope infusion
19. ST segment elevation 58 PFO PFO closure Nitroglycerin and oxygen
AV block¼ atrio-ventricular block, DILV¼ Double Inlet Left Ventricle, PS¼ Pulmonic Stenosis, TEE¼ Trans Esophageal Echocardiography, TGA¼
Transposition of the Great Arteries.
Catheterization of Adults with CHD 417
One concerning complication encountered in per-
forming cardiac catheterization in adults in our PCL
was that of hypotension. Although 9 of 12 patients who
developed hypotension during cardiac catheterization
received general anesthesia, because of the small num-
bers, the use of general anesthesia did not reach statisti-
cal significance as a causative factor. In our experience,
patients > 45 years old were significantly more likely
to develop hypotension. A blunted heart rate response
to vasodilatation secondary to anesthesia is the most
likely etiology in these patients. This is a potentially
significant issue in the patient having a past history of a
cerebral vascular accident or ischemic heart disease. It
has become our practice that during induction of anes-
thesia, the blood pressure is measured noninvasively
every 2 min, and if there is any concern, an arterial line
is placed for the patient.
Of the other major complications encountered, most
were related to the technical aspects of performing the
particular intervention. The incidence of atrial flutter
during device closure of ASD/ PFO has been reported
at 4% in the literature [14], which was similar to our
experience (2.6%). In two other patients, technical com-
plications during stent placement for treatment of native
coarctation of the aorta and conduit stenosis were
encountered. We believe that in each of these situa-
tions, performance of the catheterization procedure in a
PCL was not felt to have played a role in encountering
these particular major complications.
Only 3 patients had coronary artery disease in the
study population. It is expected that with an older popu-
lation we would have had a higher percentage of coro-
nary artery disease. Our strategy, however, would have
remained the same: we would have referred a poorly
controlled patient to the adult cardiologist for optimiza-
tion of therapy prior to taking the patient to the PCL.
Notably, none of the 96 patients with age  45 years
had a CHD-related urgent or semi-urgent issue that
necessitated a CC in a PCL prior to optimization of
therapy for other comorbid conditions.
The 32nd Bethesda Conference on adults with CHD
[15] emphasized the need for creation of regional adult
CHD centers where adult and pediatric cardiologists
would collaborate in the care of such patients under one
roof. This would be the ideal situation. Until such time
that these centers are widespread, our results suggest
that the PCL may be a safe place for cardiac catheteriza-
tion of adults with CHD after appropriate screening.
Limitations. This study is limited by its retrospective
nature.
CONCLUSIONS
This study suggests that adults patients with CHD
undergoing catheterization in a PCL have a complica-
tion risk equal to that of children with CHD undergoing
catheterization. The older subset of adult patients are
more likely to encounter complications overall. In older
patients with CHD, general anesthesia should be used
only when necessary and invasive blood pressure moni-
toring may be prudent under certain circumstances.
With screening in place, it is safe to perform cardiac
catheterization on most adults with CHD in a PCL.
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